[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603661":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":36,"collaborators":40,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":10,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":56,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"First Affiliated Hospital of Zhejiang University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"D2+CME surgery for gastric cancer",null,"D2 lymphadenectomy plus complete mesogastric excision in gastric cancer patients",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Tao Wang, Ph.d","CONTACT","+86-197-068-25286","15002740874@163.com",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine","RECRUITING","Hangzhou","Zhejiang","310000","China","CN",{"type":28,"coordinates":29},"Point",[30,31],120.16142,30.29365,{"lat":31,"lon":30},[34],{"name":35,"role":15,"phone":16,"phoneExt":10,"email":17},"Tao Wang, Ph.D",{"type":37,"investigatorFullName":38,"investigatorTitle":39,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Jichao Qin","professor",[41],{"name":42,"class":6},"Zhejiang University","100603661","the-clinical-significance-of-examining-metastatic-lymph-nodes-in-individual-gastric-mesenteries-in-the-patients-with-gastric-cancer-undergoing-gastrectomy-100603661",false,"NCT07139418","The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy","The Clinical Significance of Examining Metastatic Lymph Nodes in Respective Gastric Mesenteries in the Gastric Cancer Patients Who Received D2 Lymphadenectomy Plus Complete Mesogastric Excision","Inclusion Criteria:\n\n1. Aged older than 18 years and younger than 85 years\n2. Primary gastric adenocarcinoma confirmed by preoperative pathology result\n3. cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition\n4. Patients who received gastrectomy with D2 lymphadenectomy plus complete mesogastric excision\n5. American Society of Anesthesiologists (ASA) class I, II, or III\n6. Written informed consent\n\nExclusion Criteria:\n\n1. Negative preoperative biopsy\n2. Too late tumour stage or metastasis (cT4b\u002FM1)\n3. BMI\\>30 kg\u002Fm2\n4. Total gastrectomy or proximal gastrectomy\n5. previous neoadjuvant chemotherapy or radiotherapy\n6. Previous upper abdominal surgery\n7. Combined with other malignant diseases\n8. Reject operation","ALL","18 Years","85 Years",{"count":54,"type":55},400,"ESTIMATED","1 Month","OBSERVATIONAL","This study aims to examine the predictive value of metastatic gastric mesenteries, which contains metastatic lymph node, in 6 gastric mesenteries; and importantly, to further evaluate the relationship between the number of metastatic gastric mesenteries and prognosis in the gastric cancer patients who received D2+complete mesogastric excision (CME).",[60],"Gastric Carcinoma",[62,63,64,65],"Gastric cancer","Complete mesogastric excision","Gastric mesentery","Lymph node metastasis","2026-03-08",{"date":68,"type":69},"2026-03-11","ACTUAL",{"date":71,"type":69},"2025-10-07",{"date":73,"type":55},"2030-08-30",{"name":38,"class":6},1]